Drug Procurement Optimization

Cut Drug Acquisition Costs

DCostCheck lowers what you pay for drugs before the purchase happens. It pinpoints alternative equivalent NDCs at lower cost, averaging up to $15,000 in savings per recommendation, and compares pricing across suppliers to help you manage primary and secondary wholesaler spend strategically. 

For hospitals in the 340B program, CostCheck brings decision intelligence to 340B purchasing. It tracks WAC and GPO ratio changes, surfaces potential exclusion issues early, and sends immediate alerts when a purchase may create risk.

Health systems can also purchase select inventory directly from Pfizer Hospital, with special offers customized to their usage.

Catch and Avoid Overspending

CostCheck protects the savings you’ve already earned. Proactively monitor 100% of your contracts and invoices to catch anomalous price increases, contract misloads, and outlier accounts before they cost you. Organizations can also benchmark pricing against hospitals nationwide.

Each overcharge flag helps hospitals avoid overpayments that can exceed $100,000, while CostCheck tracks every opportunity from review through resolution – including credits, rebills, and total savings.

Drive Revenue with Reimbursement-Aware Buying Decisions

CostCheck brings margin awareness to your revenue-generating drugs – including specialty medications. By layering Medicare Part B reimbursement data directly into recommendations, every eligible alert shows cost and estimated margin impact side-by-side. Biologics and biosimilars, once compared in isolation, are now grouped for accurate cross-product margin comparison – making per-vial margin differences visible for the first time.

Coming in 2026: Connect your own claims data to CostCheck for exact, payer-level profit calculations.

Protect Against Costly Disruptions

Without visibility into purchasing strategy and external market forces, pharmacy spend can quickly escalate. CostCheck evaluates GPO compliance for every recommendation, providing line-item detail, real-time compliance status, and tracking failure-to-supply credits.

Unexpected shortages can also force hospitals into costly emergency purchases. Through an integration with ShortageCheck, hospitals can balance immediate savings opportunities with supply stability. Built-in alerts flag potential NDC shortages up to 90 days in advance, helping teams avoid switching to products that may soon become unavailable.

CostCheck’s spend monitoring verifies that purchasing aligns with preferred items while accounting for backorders, shortages, and cost-saving initiatives — closing the gap between savings identified and savings realized.